AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04972786 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: TMS pulses will be delivered through an air-cooled coil in either a figure-eight or double-cone shape, with the latter being particularly useful for targeting deeper structures such as dACC. The first phase of the TMS protocol will involve a standardized motor-thresholding procedure, wherein peripheral responses evoked by single TMS pulses are recorded via an electromyographic recording device. In this phase, the TMS coil's stimulation intensity is titrated to a level that is comfortable yet effective at reliably exciting neuronal populations orthogonal to the coil (50% motor-evoked potentials ≥50 microvolts; typical duration≈20-40 mins). Then repetitive TMS (rTMS) will be administered to a pre-determined cortical target based on the individual's pre-TMS fMRI scan using a Localite Neuronavigation system (duration≈10-20 mins). The rTMS protocol will involve the delivery of a train of TMS pulses over a cortical target prior to performance of behavioral tasks during a post-rTMS fMRI scan.
Study NCT04972786 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: TMS pulses will be delivered through an air-cooled coil in either a figure-eight or double-cone shape, with the latter being particularly useful for targeting deeper structures such as dACC. The first phase of the TMS protocol will involve a standardized motor-thresholding procedure, wherein peripheral responses evoked by single TMS pulses are recorded via an electromyographic recording device. In this phase, the TMS coil's stimulation intensity is titrated to a level that is comfortable yet effective at reliably exciting neuronal populations orthogonal to the coil (50% motor-evoked potentials ≥50 microvolts; typical duration≈20-40 mins). Then repetitive TMS (rTMS) will be administered to a pre-determined cortical target based on the individual's pre-TMS fMRI scan using a Localite Neuronavigation system (duration≈10-20 mins). The rTMS protocol will involve the delivery of a train of TMS pulses over a cortical target prior to performance of behavioral tasks during a post-rTMS fMRI scan.
Study NCT05706779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib Oral Capsule + Cetuximab
Description: Encorafenib: 4 capsules 75 mg/day (300 mg) , 7 days/7 during 6 weeks Cetuximab: 500mg/m2 intravenous route every 2 weeks (D1, D14, D28), for 3 cycles over 4 weeks.
Study NCT04809831 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Domiciliary oral care with Biorepair Peribioma Toothpaste + Mousse
Description: Patients will use Biorepair Peribioma Toothpaste and Mousse for domiciliary oral hygiene twice a day until T2 session.
Study NCT04809831 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Domiciliary oral care with Curasept Toothpaste (chlorhexidine 0,2%)
Description: Patients will use Curasept Toothpaste (chlorhexidine 0,2%) for domiciliary oral hygiene twice a day until T2 session.
Study NCT06527170 — intervention group
Intervention type: PROCEDURE
Intervention: Sleeve gastrectomy
Description: Each patient undergoes bariatric surgery. Each patient is diagnosed before surgery for erectile dysfunction. Similar tests are done 1 year after
Study NCT05324111 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kardia 6L
Description: The Kardia 6L has CE marking. The purpose of this study is to extend the use of this device by a simple modification using existing equipment in the department. The device will be connected to the left leg electrodes using standard clinical crocodile clips and the other electrode applied to the chest in V1 and V6 positions to acquire the modified V1 and V6 leads
Study NCT05298202 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Capsaicin
Description: application of capsaicin gel from shoulder to wrist and mid thigh to ankle
Study NCT05298202 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Control Gel
Description: application of hypoallergenic gel from shoulder to wrist and mid thigh to ankle
Study NCT05298202 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: treadmill walking 3.5 mph at 5% grade
Study NCT05298202 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: treadmill walking 3.5 mph at 5% grade
Study NCT05298202 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hot environment
Description: 38°C, 60% relative humidity
Study NCT05298202 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Hot environment
Description: 38°C, 60% relative humidity
Study NCT05588349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling + stretching exercise
Study NCT05588349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching exercise
Description: Stretching exercise only
Study NCT05956639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6-month course of antiandrogen drugs
Description: 6-month course of Rezvilutamide and ADT + chemotherapy
Study NCT05956639 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Long-term course of antiandrogen drugs
Description: Long-term course of Rezvilutamide and ADT + chemotherapy
Study NCT05682391 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bed rest
Description: Strict bed rest ordered after surgery that does not allow the participant to elevate the head of bed over 30 degrees
Study NCT06237582 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: epigastric lymph node biopsy
Description: epigastric lymph node biopsy and analysis to evaluate rate dissemination of ovarian carcinomatosis by this way
Study NCT04277559 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient preferential music
Description: Patients will listen to their preferred music through the headphones before surgery.
Study NCT04277559 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classical music
Description: Patients will listen to classical music through headphones before surgery.
Study NCT04277559 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No music
Description: Patients will not listen to music.
Study NCT05581602 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Wearing bracelets (3-Axis Logging Accelerometer)
Description: Participants will be required to wear wristbands containing an accelerometer on each wrist. The bracelets will be kept on both wrists for 7 days with permission to remove them from time to time.
Study NCT05581602 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearing bracelets (3-Axis Logging Accelerometer)
Description: Participants will be required to wear wristbands containing an accelerometer on each wrist. The bracelets will be kept on both wrists for 7 days with permission to remove them from time to time.
Study NCT05062122 — intervention group
Intervention type: OTHER
Intervention: vibration group
Description: Hand skills were evaluated before and after 10 minutes of vibration application.
Study NCT05062122 — intervention group
Intervention type: OTHER
Intervention: kinesiology tape group
Description: Dexterity was assessed before and after kinesiology tape application.
Study NCT05062122 — intervention group
Intervention type: OTHER
Intervention: control group
Description: Manual dexterity was assessed before and after traditional physiotherapy.
Study NCT05254665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel Polymeric Micelles for Injection
Description: Docetaxel polymeric micelles，usage and quantity of Docetaxel polymeric micelles follows the clinical study proctol，not published.
Study NCT05914948 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Medtronic 8-contact Vectris subcompact or compact electrode.
Description: Subjects meeting study eligibility criteria will be implanted with a Medtronic 8-contact Vectris subcompact or compact electrode.
Study NCT05347043 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Montreal cognitive assessment
Description: Montreal cognitive assessment and standardized neuropsychological evaluation (Test of Attentional Performance of Zimmermann and Fimm ; Wechsler Adult Intelligence Scale 4th version digit span ; Wechsler memory scale III, spatial span ; Wisconsin Card Scoring Test, GREFEX version ; Wechsler Adult Intelligence Scale 4th version block design ; Six elements test GREFEX version; free and cued selective reminding test, 16 items, B version ; Behavioral Rating Inventory of Executive Function ; Modified Fatigue Impact Scale)
Study NCT06078865 — intervention group
Intervention type: DEVICE
Intervention: FX Artificial Shoulder Prosthesis
Description: Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System,Easytech Anatomical Shoulder System, PRCT II Fracture Plate, V-135
Study NCT04253080 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Blood sample
Description: Blood sample before treatment, 3 months after treatment and after 1 year or relapse or resumption of disease progression.
Study NCT04253080 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Cutaneous melanoma biopsy
Description: Cutaneous melanoma biopsy before treatment, 3 months after treatment and relapse or resumption of disease progression.
Study NCT05497401 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MesenCure
Description: Enhanced mesenchymal cell-based product
Study NCT05497401 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline
Study NCT05074797 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: laboratory
Description: laboratory data
Study NCT05111860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab+mFOLFOX6
Description: Bevacizumab 5mg/kg d1 Oxaliplatin 85mg/m2 d1 Calcium Folinate 400mg/m2 d1 5-fluorouridine 400mg/m2 d1 5-fluorouridine 2400mg/m2 46h q2w, 6 cycles
Study NCT04554420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Participatory Action Research-Mental Health Curriculum
Description: The mental health curriculum will focus on enhancing the knowledge, critical consciousness (i.e., exploration of systemic/racial problems), research self-efficacy, and other skills of youth to integrate their lived experiences and identity to learning about the intersection of system and community level issues in mental health. Activities will center on participatory action approaches to engaging youth in culturally/community responsive ways.
Study NCT05723224 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: elective endoscopic gallbladder treatment
Description: Access to the gallbladder will be performed from the stomach or duodenum using LAMS with electrocautery-enhanced delivery system such as Hot Axios, Boston Scientifics device or Hot Spaxus, Taewoong at the discretion of the endoscopist. A stent of 10 mm in diameter will be used if the largest gallstone will be smaller than 10 mm in size while greater diameter (≥15 mm stent) will be used if the largest gallstone will be larger than 10mm. Colecystoscopy lithotripsy will be performed, when needed, using mechanical lithotripsy and/or laser lithotripsy at the discretion of the endoscopist. First cholecystoscopy will be done 2 weeks after the index procedure
Study NCT05404243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: phenolization
Description: In case of phenolization group, an Abbocath catheter 18 G is introduced into the cystic cavity. Undiluted 88% phenol is instilled into the cavity, ensuring that the cystic cavity is filled. It is maintained for 5 min until complete coagulation of the cyst is achieved.
Study NCT05404243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional surgery
Description: In case of conventional surgery, entire exeresis is performed by means of an electric scalpel
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b5 Bivalent (WT/OMI BA.2)
Description: BNT162b5 Wild Type and BNT162b5 OMICRON \[B.1.1.529 sublineage BA.2\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2 Bivalent (WT/OMI BA.1)
Description: BNT162b2 Wild Type and BNT162b2 OMICRON \[B.1.1.529 sublineage BA.1\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2 Bivalent (WT/OMI BA.4/BA.5)
Description: BNT162b2 Wild Type and BNT162b2 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BNT162b2 Bivalent (WT/OMI BA.4/BA.5)
Description: BNT162b2 Wild Type and BNT162b2 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT06445829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Description: adding 300mg magnesium sulfate into cocktail injection
Study NCT04910607 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire with 4 axes:~sociological, reflexive medical, prospective medical, transversal
Study NCT04910607 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b5 Bivalent (Original/OMI BA.4/BA.5)
Description: BNT162b5 Wild Type and BNT162b5 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b6 Bivalent (Original/OMI BA.4/BA.5)
Description: BNT162b6 Wild Type and BNT162b6 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b7 Bivalent (Original/OMI BA.4/BA.5)
Description: BNT162b7 Wild Type and BNT162b7 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT05472038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b7 Monovalent (OMI BA.4/BA.5)
Description: BNT162b7 OMICRON \[B.1.1.529 sublineage BA.4/BA.5\]
Study NCT05084313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy
Description: This group of patients will receive manual therapy techniques to harmonize vegetative nervous system. PPG and GSR will be recorded during the intervention. The techniques consist of CV-4 technique, suboccipital decompression, lumbo-sacral decompression, release of the transverse diaphragms, frontal lift technique, parietal lift technique, temporal techniques, temporo-mandibular joint myofascial release, deep cervical fasciae technique as described in Upledger's protocol. In addition to the protocol; rib raising technique, larynx and sternocleidomastoid muscle fascial release and occipito-mastoid suture release will be applied. All intervention is planned to take approximately 20 minutes. The group will include forty healthy individuals.
Study NCT05084313 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deep-slow breathing
Description: Patients in this group will do slow paced breathing to increase heart rate variability as it can be partially modulated by respiratory effects. The patients will be able to cease the session in case of feeling uncomfortable. The main purpose will be that the individuals should breathe six breaths per minute to increase respiratory sinus arrhythmia which is also reflected at PPG waveforms and in reduction in GSR. The group will include forty healthy individuals.
Study NCT05084313 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Control group patients will be attached to the sensors, and they will rest in a quiet and controlled indoor environment without any intervention. The aim of including this group is to to understand whether the parasympathetic effects expected in the manual therapy group were due to the intervention. The group will include forty healthy individuals.
Study NCT05822934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin-Gemcitabine Cisplatin-Gemcitabine
Description: Carboplatin-gemcitabine versus cisplatin-gemcitabine as neoadjuvant chemotherapy for treatment of muscle invasive urinary bladder cancer
Study NCT05822934 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin-Gemcitabine Cisplatin-Gemcitabine
Description: Carboplatin-gemcitabine versus cisplatin-gemcitabine as neoadjuvant chemotherapy for treatment of muscle invasive urinary bladder cancer
Study NCT05279352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FBR-002
Description: Administration on D1 and D3
Study NCT05279352 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration on D1 and D3
Study NCT05835765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamic Elastometric Body in Preterm Newborns
Description: The study group made up of 12 newborns will use Flexa bodysuits made to the measurements of newborns.The bodysuit will be worn for a minimum of 4 hours and a maximum of 6 hours each day for a week (depending on any signs of discomfort). After 6 hours, the body will be removed and reapplied the next day for 4-6 hours. The child will use the same leotard for the entire study period (1 week) and changed only if dirty.
Study NCT05952232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: PA-GH-01
Description: 1 capsule after breakfast once a day
Study NCT05952232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: MK-GH-04
Description: 1 capsule after breakfast once a day
Study NCT05952232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: TSH-GH-03
Description: 1 capsule after breakfast once a day
Study NCT05952232 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: PA-GH-02
Description: 1 capsule after breakfast once a day
Study NCT04903782 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Family-based whole genome sequencing
Description: 1. Germline whole-genome family-based sequencing and variant identification.~2. Multidisciplinary Meeting case discussion.~3. Recommendation of referral to a Cancer Genetics Clinic for further investigation, follow up and/or genetic counselling.~4. Psychosocial study to analyse the impact of germline sequencing on families.
Study NCT05041231 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBT)
Description: Any invasive procedures will be done. The treatment in question will be done by a device that looks like a bracelet, which is placed on the hand/fingers to emit light/laser and does not cause pain or temperature change. There will be 8 photobiomodulation sessions, 2 per week, 10 minutes each session.~The dosimetric parameters of the therapy will be carried out in a standardized and personalized way, with programming of the light and all the necessary information so that the device can carry out the application of the treatment application of electromagnetic waves in the red and infrared spectral range 660-1000 nm).
Study NCT05041231 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Photobiomodulation therapy (Sham PBT)
Description: Similar to active PBT, however, the device will not provide the active electromagnetic waves)
Study NCT04396366 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active drug
Description: QBW251 Capsule 300mg Oral use, one capsule twice daily.
Study NCT04396366 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Capsule 300mg Oral use, one capsule twice daily.
Study NCT05968677 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: FSMP
Description: Food for Special Medical Purposes specifically formulated for the dietary management of malnourished patients following therapeutic treatments such as chemo and radiotherapy
Study NCT05968677 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Nutritional counseling
Description: Participant's nutritional status will be evaluated, anthropometric data will be collected (weight, height, BMI), body composition will be evaluated (FFMI, BIVA) and a food diary will be compiled
Study NCT05968677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Description: Participant's nutritional status will be evaluated, anthropometric data will be collected (weight, height, BMI), body composition will be evaluated (FFMI, BIVA) and a food diary will be compiled
Study NCT06143358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qingkepingchuan Granules
Description: Qingkepingchuan Granules,Take it three times a day with water after meals.
Study NCT06143358 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional treatment
Description: Oxygen intake, selection of appropriate antibiotics based on lab results, and other treatments
Study NCT05710055 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Study product A (Wonderlab wonder4shape)
Description: Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months
Study NCT05710055 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Study product B (Wonderlab wonder4shape)
Description: Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months
Study NCT05710055 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Study product C (Wonderlab wonder4shape)
Description: Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months
Study NCT05710055 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Study product D
Description: Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months
Study NCT05963490 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Regorafenib
Description: Regorafenib 120 mg orally once daily on days 1-21 of each 28 days cycle.
Study NCT05963490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: 240 mg intravenously every 3 weeks